Clinical Trials Directory

Trials / Completed

CompletedNCT07357194

Renal Rehabilitation Among Patients With Kidney Failure

Barriers to Renal Rehabilitation Among Patients With Kidney Failure in Governmental Hospitals in Cairo: A Cross-Sectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
158 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to identify and analyze the barriers to renal rehabilitation among patients diagnosed with kidney failure in Cairo

Detailed description

This study is a cross-sectional design aimed at identifying the barriers to renal rehabilitation among patients diagnosed with kidney failure in governemtnal hospitals in Cairo. The sample size for this study was determined using G\*POWER statistical software (version 3.1.9.2; Franz Faul, Universitat Kiel, Germany) and was based on a previous study by (Bossola et al., 2014). which reported a prevalence of 38.1%. The required sample size calculated for this study is N=155, with calculations made using a significance level (α) of 0.05 and a statistical power of 80%. This sample size is deemed appropriate for achieving the study's objectives and ensuring statistically significant results. 155 patients suffering from kidney failure will participate in the study. They will be selected randomly from the different governmental hospitals centers in Cairo, Informed consent Freely and voluntarily consent to participate in this research study (Effect of pelvic floor down-training exercise on females with idiopathic overactive bladder) under the supervision and direction of the researcher/ Merna Mabrouk A thorough description of the study procedures has been explained to me, and I understand that I may withdraw my consent and discontinue participation in this study research at any time without prejudice to me.

Conditions

Timeline

Start date
2024-11-17
Primary completion
2025-01-30
Completion
2025-01-30
First posted
2026-01-21
Last updated
2026-01-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07357194. Inclusion in this directory is not an endorsement.